Physician profile
Ryan Hostutler
NPI 1336559830
$8,195.16
in general payments reported to CMS, 2019-2025
23 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.14 · 2020: $2,254 · 2021: $1,138 · 2022: $2,008 · 2023: $1,243 · 2024: $807 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,613.67 | 2020-2025 | Eterna, Proclaim |
| Medtronic, INC. | $1,755.12 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Vertos Medical, INC. | $805.88 | 2020-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $355.75 | 2020-2025 | Xifaxan |
| Relievant Medsystems, INC. | $355.50 | 2020-2023 | Intracept |
| Saluda Medical Americas, INC. | $332.45 | 2023-2024 | Evoke Scs, Evoke |
| Averitas Pharma INC. | $297.36 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $287.22 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, General - Therapies |
| Nevro Corp. | $223.27 | 2022 | |
| Curonix LLC | $199.28 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $177.67 | 2020-2025 | Ha Minuteman G3-R |
| Forte Bio-Pharma LLC | $170.44 | 2020-2021 | |
| Si-Bone, INC. | $165.63 | 2022 | |
| Biodelivery Sciences International, INC. | $101.92 | 2020-2021 | |
| Novo Nordisk INC | $87.33 | 2022-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $83.34 | 2024 | Excelsius Deformity |
| Redhill Biopharma INC. | $45.58 | 2020-2021 | |
| Mml US, INC. | $43.53 | 2025 | Reactiv8 |
| Arbor Pharmaceuticals, INC. | $34.86 | 2020 | |
| Scilex Pharmaceuticals INC. | $19.00 | 2020 | |
| Indivior INC. | $14.14 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.00 | 2022 | |
| Almatica Pharma LLC | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hostutler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.